B. Rumble

1.6k total citations · 1 hit paper
12 papers, 1.3k citations indexed

About

B. Rumble is a scholar working on Physiology, Molecular Biology and Pharmacology. According to data from OpenAlex, B. Rumble has authored 12 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Physiology, 8 papers in Molecular Biology and 3 papers in Pharmacology. Recurrent topics in B. Rumble's work include Alzheimer's disease research and treatments (10 papers), Amyloidosis: Diagnosis, Treatment, Outcomes (5 papers) and Cholinesterase and Neurodegenerative Diseases (2 papers). B. Rumble is often cited by papers focused on Alzheimer's disease research and treatments (10 papers), Amyloidosis: Diagnosis, Treatment, Outcomes (5 papers) and Cholinesterase and Neurodegenerative Diseases (2 papers). B. Rumble collaborates with scholars based in Australia and Germany. B. Rumble's co-authors include Colin L. Masters, Konrad Beyreuther, Ralph N. Martins, Ashley I. Bush, Robert D. Moir, Gerd Multhaup, C. Hilbich, Robert W. Retallack, Philip Montgomery and G. Simms and has published in prestigious journals such as New England Journal of Medicine, Journal of Biological Chemistry and Blood.

In The Last Decade

B. Rumble

12 papers receiving 1.3k citations

Hit Papers

Amyloid A4 Protein and Its Precursor in Down's Syndrome a... 1989 2026 2001 2013 1989 100 200 300 400 500

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
B. Rumble Australia 9 1.0k 512 213 161 156 12 1.3k
E. Matsubara Japan 12 1.2k 1.1× 735 1.4× 177 0.8× 82 0.5× 200 1.3× 24 1.6k
Walter J. Brecht United States 14 1.1k 1.0× 852 1.7× 143 0.7× 98 0.6× 183 1.2× 22 2.0k
Loren Lindsley United States 5 998 1.0× 550 1.1× 124 0.6× 59 0.4× 218 1.4× 5 1.5k
Alexei R. Koudinov Russia 18 906 0.9× 621 1.2× 96 0.5× 76 0.5× 140 0.9× 26 1.4k
Masaki Imagawa Japan 15 887 0.9× 570 1.1× 254 1.2× 68 0.4× 120 0.8× 21 1.2k
Antonella Vitali Italy 12 779 0.8× 480 0.9× 95 0.4× 71 0.4× 133 0.9× 16 1.1k
Inge Grundke-Iqbal United States 8 983 1.0× 844 1.6× 100 0.5× 43 0.3× 159 1.0× 8 1.6k
Catherine Malaplate‐Armand France 17 521 0.5× 438 0.9× 86 0.4× 135 0.8× 153 1.0× 30 1.0k
Doris Dea Canada 21 745 0.7× 514 1.0× 104 0.5× 51 0.3× 207 1.3× 35 1.3k

Countries citing papers authored by B. Rumble

Since Specialization
Citations

This map shows the geographic impact of B. Rumble's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by B. Rumble with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites B. Rumble more than expected).

Fields of papers citing papers by B. Rumble

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by B. Rumble. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by B. Rumble. The network helps show where B. Rumble may publish in the future.

Co-authorship network of co-authors of B. Rumble

This figure shows the co-authorship network connecting the top 25 collaborators of B. Rumble. A scholar is included among the top collaborators of B. Rumble based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with B. Rumble. B. Rumble is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
1.
Macrides, Theodore A., et al.. (1995). Antiarthritic mechanisms of lupeol triterpenes. Drug Development Research. 36(1). 20–24. 10 indexed citations
2.
Field, Barry, et al.. (1995). Esterification improves antiarthritic effectiveness of lupeol. Drug Development Research. 35(3). 137–141. 17 indexed citations
5.
Bush, Ashley I., Gerhard Multhaup, Robert D. Moir, et al.. (1993). A novel zinc(II) binding site modulates the function of the beta A4 amyloid protein precursor of Alzheimer's disease. Journal of Biological Chemistry. 268(22). 16109–16112. 231 indexed citations
6.
Bush, Ashley I., Scott Whyte, Timothy G. Williamson, et al.. (1992). An abnormality of plasma amyloid protein precursor in Alzheimer's disease. Annals of Neurology. 32(1). 57–65. 47 indexed citations
7.
Moir, Robert D., Ralph N. Martins, Ashley I. Bush, et al.. (1992). Human Brain βA4 Amyloid Protein Precursor of Alzheimer's Disease: Purification and Partial Characterization. Journal of Neurochemistry. 59(4). 1490–1498. 43 indexed citations
8.
Bush, Ashley I., Timothy G. Williamson, Robert D. Moir, et al.. (1992). Plasma amyloid precursor protein is a marker for alzheimer’s disease. Pathology. 24. 24–24. 1 indexed citations
9.
Whyte, Scott, Ashley I. Bush, Jon Currie, et al.. (1992). The abnormality of plasma amyloid protein precursor in Alzheimer's disease. Neurobiology of Aging. 13. S29–S29. 1 indexed citations
10.
Beyreuther, Konrad, Ashley I. Bush, Thomas Dyrks, et al.. (1991). Mechanisms of Amyloid Deposition in Alzheimer's Diseasea. Annals of the New York Academy of Sciences. 640(1). 129–139. 52 indexed citations
11.
Bush, Ashley I., Ralph N. Martins, B. Rumble, et al.. (1990). The amyloid precursor protein of Alzheimer's disease is released by human platelets.. Journal of Biological Chemistry. 265(26). 15977–15983. 270 indexed citations
12.
Rumble, B., Robert W. Retallack, C. Hilbich, et al.. (1989). Amyloid A4 Protein and Its Precursor in Down's Syndrome and Alzheimer's Disease. New England Journal of Medicine. 320(22). 1446–1452. 519 indexed citations breakdown →

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026